• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gyre Therapeutics, Inc. - Common Stock (NQ: GYRE )

    14.97 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Gyre Therapeutics, Inc. - Common Stock

    < Previous 1 2 Next >
    Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024
    Gyre Therapeutics just reported results for the second quarter of 2024. 
    Via InvestorPlace
    GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q1 2024
    Gyre Therapeutics just reported results for the first quarter of 2024. 
    Via InvestorPlace
    Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Gyre Therapeutics to Present at Sidoti Virtual Investor Conference
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
    Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in... 
    Via Talk Markets
    Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Heico Posts Upbeat Earnings, Joins Surmodics, Abercrombie & Fitch And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Why NetEase Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
    We’re using the Portfolio Grader to find the best biotech stocks to buy in today’s market. Each of these stocks get top grades. 
    Via InvestorPlace
    Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter financial results. 
    Via Benzinga
    Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
    U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NASDAQ: ELVN) rose sharply during Thursday’s session. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
    From Gyre Therapeutics, Inc.
    Via GlobeNewswire
    Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why MercadoLibre Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Shares of MercadoLibre, Inc. (NASDAQ: MELI) fell sharply during Friday’s session after the company reported fourth-quarter financial results. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Carvana Posts Q4 Results, Joins LegalZoom.com, Comfort Systems And Other Big Stocks Moving Higher On Friday
    U.S. stocks were mostly higher, with the Dow Jones index gaining more than 100 points on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On Friday
    U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Friday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.